Yao‐Wen Jiang

State Key Laboratory of Digital Medical Engineering

Papers

1

Total Citations

45

H-Index

1

About

Yao-Wen Jiang is a rising leader in bionic drug delivery systems, whose work focuses on overcoming the complex biological barriers that limit cancer therapy. His most notable contribution is the development of a red blood cell-derived bionic microrobot, detailed in his highly cited 2023 paper (45 citations). This innovative platform is uniquely designed to hierarchically adapt to five critical stages of systemic drug delivery—from circulation to subcellular targeting—dramatically improving tumour-targeting efficiency. By mimicking the natural properties of red blood cells, Jiang’s microrobot addresses longstanding challenges in chemotherapy, offering a smarter, more effective approach to anticancer treatment. His research sits at the intersection of biomimetics, nanomedicine, and robotics, and his work is already shaping next-generation drug delivery strategies. With growing recognition for his ability to engineer systems that navigate physiological barriers, Jiang is establishing himself as a key innovator in precision medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
A red blood cell‐derived bionic microrobot capable of hierarchically adapting to five critical stages in systemic drug delivery
45 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: State Key Laboratory of Digital Medical Engineering

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago